TREATMENT OF THE DISEASE IN PATIENTS WITH CIRRHOSIS OF THE LIVER
Keywords:
modern treatments, symptoms, approaches, patients, infections, etiologies.Abstract
Cirrhosis of the liver is a chronic and progressive condition characterized by the replacement of healthy liver tissue with scarred, fibrotic tissue. This debilitating disease poses a significant challenge to healthcare professionals, as it often presents with a complex array of symptoms and comorbidities that require a multifaceted treatment approach. In this comprehensive article, we will delve into the intricacies of managing cirrhosis in patients, exploring the various treatment modalities, their efficacy, and the importance of a holistic approach to patient care.
References
Ahmed MH, Byrne CD. Obstructive sleep apnea syndrome and fatty liver: association or causal link? World J Gastroenterol. 2010 Doi: 10.3748/wjg. v16.i34.4243.
Bruyneel M, Serrate T. Sleep disturbances in patients with liver cirrhosis: prevalence, impact, and management challenges. Nat Sci Sleep. 2018; 10:369. Doi: 10.2147/NSS.S186665.
Jopson L, Dyson JK, Jones DEJ. Understanding and treating fatigue in primary biliary cirrhosis and primary sclerosing cholangitis. Clin Liver Dis. 2016;20(1):131–142. Doi: 10.1016/J.CLD.2015.08.007.
Bajaj JS, Ellwood M, Ainger T, et al. Mindfulness-based stress reduction therapy improves patient and caregiver-reported outcomes in cirrhosis. Clin Trans Gastroenterol. 2017;8(7): e108. Doi: 10.1038/CTG.2017.38.
Piche T, Amberlite G, Cheikh F, et al. Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomized, double blind, placebo-controlled study. Gut. 2005;54(8):1169–1173. Doi: 10.1136/GUT.2004.055251.
Silveira MG, Gossard AA, Stahler AC, et al. A randomized, placebo-controlled clinical trial of efficacy and safety: modafinil in the treatment of fatigue in patients with primary biliary cirrhosis. Am J Ther. 2017;24(2): e167–e176. Doi: 10.1097/MJT.0000000000000387.
Spahr L, Centaur A, Giustra E, Dengue A, Annoni JM. Histamine H1 blocker hydroxyzine improves sleep in patients with cirrhosis and minimal hepatic encephalopathy: a randomized controlled pilot trial. Am J Gastroenterol. 2007;102(4):744–753. Doi: 10.1111/J.1572-0241.2006.01028. X.
Sharma MK, Kainth S, Kumar S, et al. Effects of zolpidem on sleep parameters in patients with cirrhosis and sleep disturbances: a randomized, placebo-controlled trial. Clin Mol Hepatol. 2019;25(2):199. Doi: 10.3350/CMH.2018.0084.
